Some claim the European Union is lashing out at drugmaker AstraZeneca to distract attention from its own slow and shambolic vaccine programme. But is this picture accurate? Or is the EU, by threatening to block vaccine exports, acting in a reasonable way to protects its interests? Ben Chu investigates
